UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $308
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $288 to $308.
UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $288 to $308.